Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.930
-0.030 (-1.53%)
Nov 21, 2024, 11:04 AM EST - Market open
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $174.77 million as of November 21, 2024. Its market cap has decreased by -58.50% in one year.
Market Cap
174.77M
Enterprise Value
-76.89M
1-Year Change
-58.50%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $174.77M, a decrease of -80.33%. That is a compound annual growth rate of -38.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 180.20M | -64.44% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accuray | 185.04M |
| Heron Therapeutics | 180.99M |
| Nanobiotix | 180.70M |
| Inozyme Pharma | 180.51M |
| Biodesix | 180.38M |
| Tenaya Therapeutics | 179.83M |
| BrainsWay | 176.99M |
| Verastem | 176.25M |